![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PDPR |
Gene summary for PDPR |
![]() |
Gene information | Species | Human | Gene symbol | PDPR | Gene ID | 55066 |
Gene name | pyruvate dehydrogenase phosphatase regulatory subunit | |
Gene Alias | PDP3 | |
Cytomap | 16q22.1 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q8NCN5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55066 | PDPR | LZE4T | Human | Esophagus | ESCC | 3.37e-02 | 1.04e-01 | 0.0811 |
55066 | PDPR | LZE7T | Human | Esophagus | ESCC | 1.46e-05 | 1.85e-01 | 0.0667 |
55066 | PDPR | LZE8T | Human | Esophagus | ESCC | 3.97e-02 | 3.41e-02 | 0.067 |
55066 | PDPR | LZE24T | Human | Esophagus | ESCC | 4.09e-11 | 1.80e-01 | 0.0596 |
55066 | PDPR | P1T-E | Human | Esophagus | ESCC | 5.08e-08 | 4.86e-01 | 0.0875 |
55066 | PDPR | P2T-E | Human | Esophagus | ESCC | 5.03e-11 | -9.27e-04 | 0.1177 |
55066 | PDPR | P4T-E | Human | Esophagus | ESCC | 8.03e-06 | 8.44e-02 | 0.1323 |
55066 | PDPR | P5T-E | Human | Esophagus | ESCC | 2.81e-21 | 6.99e-02 | 0.1327 |
55066 | PDPR | P8T-E | Human | Esophagus | ESCC | 6.87e-10 | 1.42e-01 | 0.0889 |
55066 | PDPR | P10T-E | Human | Esophagus | ESCC | 4.29e-13 | 1.77e-01 | 0.116 |
55066 | PDPR | P11T-E | Human | Esophagus | ESCC | 8.33e-11 | 2.37e-01 | 0.1426 |
55066 | PDPR | P12T-E | Human | Esophagus | ESCC | 1.52e-08 | -1.86e-03 | 0.1122 |
55066 | PDPR | P15T-E | Human | Esophagus | ESCC | 4.31e-14 | 3.26e-01 | 0.1149 |
55066 | PDPR | P16T-E | Human | Esophagus | ESCC | 3.46e-12 | 6.15e-02 | 0.1153 |
55066 | PDPR | P20T-E | Human | Esophagus | ESCC | 2.80e-07 | 7.88e-02 | 0.1124 |
55066 | PDPR | P21T-E | Human | Esophagus | ESCC | 2.35e-24 | 1.87e-01 | 0.1617 |
55066 | PDPR | P22T-E | Human | Esophagus | ESCC | 2.96e-13 | 2.90e-02 | 0.1236 |
55066 | PDPR | P23T-E | Human | Esophagus | ESCC | 3.57e-11 | 1.57e-01 | 0.108 |
55066 | PDPR | P24T-E | Human | Esophagus | ESCC | 5.51e-07 | -1.35e-02 | 0.1287 |
55066 | PDPR | P26T-E | Human | Esophagus | ESCC | 5.50e-22 | 1.56e-01 | 0.1276 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PDPR | SNV | Missense_Mutation | novel | c.1965G>T | p.Glu655Asp | p.E655D | Q8NCN5 | protein_coding | deleterious(0.03) | benign(0.248) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PDPR | SNV | Missense_Mutation | c.480N>T | p.Lys160Asn | p.K160N | Q8NCN5 | protein_coding | tolerated(0.15) | benign(0.115) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD | |
PDPR | SNV | Missense_Mutation | rs373874803 | c.158N>T | p.Thr53Met | p.T53M | Q8NCN5 | protein_coding | tolerated(0.83) | benign(0.003) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
PDPR | SNV | Missense_Mutation | novel | c.840N>G | p.Ser280Arg | p.S280R | Q8NCN5 | protein_coding | tolerated(0.46) | benign(0.125) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
PDPR | SNV | Missense_Mutation | novel | c.784N>A | p.Ala262Thr | p.A262T | Q8NCN5 | protein_coding | tolerated(0.06) | possibly_damaging(0.876) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
PDPR | SNV | Missense_Mutation | novel | c.2348N>A | p.Pro783His | p.P783H | Q8NCN5 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
PDPR | SNV | Missense_Mutation | rs774452507 | c.2297G>A | p.Arg766His | p.R766H | Q8NCN5 | protein_coding | deleterious(0.01) | possibly_damaging(0.862) | TCGA-AX-A3FT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PDPR | SNV | Missense_Mutation | c.2108N>A | p.Arg703Gln | p.R703Q | Q8NCN5 | protein_coding | tolerated(0.16) | possibly_damaging(0.59) | TCGA-B5-A11Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Hormone Therapy | megace | SD | |
PDPR | SNV | Missense_Mutation | novel | c.297N>T | p.Gln99His | p.Q99H | Q8NCN5 | protein_coding | tolerated(0.13) | possibly_damaging(0.704) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
PDPR | SNV | Missense_Mutation | novel | c.2279N>G | p.Gln760Arg | p.Q760R | Q8NCN5 | protein_coding | tolerated(0.16) | benign(0.038) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |